# Low dosE GlibENclamide in Diabetes Part A

> **NCT02830048** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 16 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Glibenclamide

## Key facts

- **NCT ID:** NCT02830048
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2017-03-09
- **Final completion:** 2017-03-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02830048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02830048, "Low dosE GlibENclamide in Diabetes Part A". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02830048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*